Skip to main content

Radiation Dose Management Market growing at a CAGR of10.96% between 2021-2030

 Since the discovery of X-ray and ionizing radiations in the 1890s, the probable prospects of radiation usage for diagnosis were explored and studied. Further innovations in the field of medical devices paved the way for better application of radiation. The radiology sector has rapidly evolved in recent years with the emergence of advanced imaging technologies, capturing and interpreting the diseases, which can be later explored for disease monitoring and treatment.

However, the rising usage of radiation-derived technologies has led to an upsurge of consequences that pose a threat to human lives. This is one of the significant challenges concerning overexposures and has pressured the regulatory bodies to formulate laws with respect to dose monitorization. Thus, systematic and constant monitoring of radiation dose is vital to increase the overall quality of the radiological services to patients. Additionally, dose monitoring rises awareness among hospital staff, radiographers, radiologists, and medical physicists with improved dosimetry statistics.

The global radiation dose management market is driven by increasing installed bases of radiology and number of scans, growing geriatric population, and the increasing prevalence of chronic and lifestyle-associated diseases, such as cancer, respiratory disease, and cardiovascular diseases.

However, many hospitals have not historically used radiation dose management software as a quality benchmarking tool. With the rising prevalence of cancer cases or chronic diseases, coupled with the implementation of strict guidelines that mandate to regulate the minimal dose exposed through a product, led to the adoption of radiation management tools. This has enhanced the IT integration and interoperability of both patient and staff dose data to accurately track, capture, and measure information to assess quality in the long term.

Rising demand for radiation dose management awareness, increasing geriatric population, and increasing install base of radiology products are some of the factors promoting the growth of radiation dose management software in this region. The radiation dose management market is expected to reach $567.3 million by 2030, growing at a CAGR of10.96% during the forecast period 2021-2030. Major growth factors driving the market include the increasing incidence of lifestyle-related diseases and the rising demand for radiation-based diagnostic devices.

The presence of limited companies in the radiation dose management industry and the increasing regulations for radiation dose have increased the competition in the global market. Increasing awareness regarding radiation over exposure and its side-effects have increased the demand for radiation dose management software.

The radiation dose management market is gradually growing over time, compelling several companies to come up with collaborative strategies to sustain the intensely competitive market. Companies with identical goals pool in resources and sign agreements to assist each other in achieving those goals. The software platform permits medical professionals to manage, examine, and optimize dose delivered to patients during interventional procedures, medical imaging examination, and image-guided surgery.

The radiation dose management market is witnessing a significant increase in the market size due to the ongoing COVID-19 pandemic. The overall market was estimated to be $231.1 million in FY2019, and it is expected to grow at a CAGR of 10.96% during the forecast period, 2021-2030. Presently, more than 21 companies are operating in this market, including already existing and emerging medical device companies.

Request a Sample - https://bisresearch.com/requestsample?id=1053&type=download







Comments

Popular posts from this blog

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

  The global  hyperspectral imaging market  was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases.   COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...